³Ô¹ÏÍøÕ¾

Latest adenocarcinoma News

Mitochondrial DNA Levels Impact Tumor Size
Researchers gain insights into KRAS mutations in pancreatic cancers
ITM Obtains Exclusive Worldwide License from Debiopharm for CA IX-Targeted Peptide-based Radiopharmaceutical Programs Targeting Solid Tumors
Survivor Joins Cancer Campaign
New research shows more than three times as many cancers are attributable to physical inactivity than previously estimated
Bright ideas attract major funding
FDA grants fast-track designation for EnGeneIC’s pancreatic cancer candidate
EnGeneIC granted FDA “Fast-Track” Designation for Novel Armed Nanocell Drug Conjugate (ANDC) Pancreatic Cancer Therapeutic
EnGeneIC’s breakthrough Armed Nanocell Drug Conjugate (ANDC) treatment shows promising results in Pancreatic cancer patients who have run out of treatment options
Landmark blood test to detect silent, lethal cancer
How cancer works – decade’s research unlocks secrets
November is Pancreatic Cancer Awareness Month
Raising Pancreatic Cancer Awareness in November
Early diagnosis a step closer for those at risk of oesophageal cancer
Pharmaxis announces the publication of positive preclinical data for PXS-5505
Drug that targets scar-like tissue in tumours shows promise for pancreatic cancer
Drug that targets scar-like tissue in tumours shows promise
6 things to know about pancreatic cancer 18 August
Peptomyc Announces the Approval of Its Phase 1b Trial Testing OMO-103 in Combination With Standard of Care in PDAC Patients
Ludwig Cancer Research study shows tumor monocyte content predicts immunochemotherapy outcomes for esophageal cancer
Differences in animal biology can affect cancer drug development
Eliminating partners of cancer
Enhertu recommended for approval in EU by CHMP for patients with previously treated HER2-positive advanced gastric cancer
ESMO 2022: Clinical trial updates
Baylor College of Medicine recruiting volunteers for pancreatic cancer clinical trial
Mapping ‘energy fingerprints’ of lung cancer leads to fundamental treatment rethink
Commercial agreement aims to increase early detection of oesophageal cancer
Bowel cance on rise in under 50s over past three decades
New appointment to Imugene’s scientific advisory board
Amplia says new report ‘paves way’ for its phase 2 trial
Ludwig Princeton preclinical study shows ketogenic diet could enhance pancreatic cancer therapy
AstraZeneca aims to redefine liver, biliary tract and prostate cancer treatment with practice-changing Imfinzi and Lynparza data
Gold-based cancer therapy could face competition from other substances
Cervical Screening Saves Young Woman’s Life
Pancreatic cancer ‘priming’ may make chemotherapy more effec
New evidence of dangers of high-fat diet on pre-cancerous condition